Table 1.
HCC incidence during follow-up | No HCC during follow-up | Total | |
MIB-1 > 1 | 40 | 46 | 86 |
MIB-1 ≤ 1 | 6 | 13 | 19 |
PCNA > 4 | 23 | 23 | 46 |
PCNA ≤ 4 | 23 | 36 | 59 |
Total | 46 | 59 | 105 |
HCC incidence during follow-up | No HCC during follow-up | Total | |
MIB-1 > 1 | 40 | 46 | 86 |
MIB-1 ≤ 1 | 6 | 13 | 19 |
PCNA > 4 | 23 | 23 | 46 |
PCNA ≤ 4 | 23 | 36 | 59 |
Total | 46 | 59 | 105 |